Creo Medical Share Price | |
---|---|
Price | 36.00 |
Bid | 35.00 |
Ask | 37.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 36.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £131.04m |
Market Size | 5,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -2.504076 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
25-Apr-24 | 16:28:25 | 36.006 | 14,525 | Sell* | 36.00 | 36.50 | 5,230 | O Ordinary |
25-Apr-24 | 16:22:09 | 36.50 | 5 | Buy* | 36.00 | 36.50 | 1.83 | O Ordinary Trade was executed as an SI |
25-Apr-24 | 16:22:09 | 36.00 | 52 | Sell* | 36.00 | 36.50 | 18.72 | O Ordinary Trade was executed as an SI |
25-Apr-24 | 16:22:09 | 36.50 | 5 | Buy* | 36.00 | 36.50 | 1.83 | O Ordinary Trade was executed as an SI |
25-Apr-24 | 16:10:38 | 36.006 | 3,750 | Sell* | 36.00 | 36.50 | 1,350 | O Ordinary |
25-Apr-24 | 16:09:53 | 36.14 | 2,147 | Sell* | 36.00 | 36.50 | 775.93 | O Ordinary |
25-Apr-24 | 16:04:25 | 36.30 | 300 | Buy* | 36.00 | 36.50 | 108.90 | O Ordinary |
25-Apr-24 | 16:03:51 | 36.14 | 7,500 | Sell* | 36.00 | 36.50 | 2,711 | O Ordinary |
25-Apr-24 | 16:02:05 | 36.50 | 11 | Buy* | 36.00 | 36.50 | 4.02 | O Ordinary |
25-Apr-24 | 15:56:50 | 36.005 | 25,000 | Sell* | 36.00 | 36.50 | 9,001 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |